Apex Medilink Private Limited - Due diligence report

A 360° intelligence report on Apex Medilink Private Limited: trust score, financial health, credit view, compliance, directors, growth and d…

2002-02-26 Kolkata, West Bengal Active Unlisted Active Compliant
Connect MCP
AM Apex Medilink Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Apex Medilink Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
90/100
Trust Score
Low Risk

Apex Medilink Private Limited is assessed as Low Risk with a Trust Score of 90/100. Apex Medilink Private Limited is an active private limited indian non-government company incorporated in 2002, operating in the Healthcare sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 10 Aug 2026 from the latest processed filings. Apex Medilink Private Limited snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
90/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
75/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 55/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SHYAMA PAUL 01234567 Director 01/04/2018 6 yrs Approved
SUPRIYA CHOWDHURY 01234567 Director 01/04/2018 6 yrs Approved
PATIT PABAN CHOWDHURY 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2019 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Vip Apex Medical Centre Private Limited
Subsidiaries
-
Group entities
-
Capital events
3 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Vip Apex Medical Centre Private Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 90
Growth signals & trust indicators
Latest year revenue grew 38%.
Profit expanded 1.42 year-on-year.
Operating for 24+ years.
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence94/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment72/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view73/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 13 events
15 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
28 Aug 2017
Director ceased
TAPAN KUMAR CHAKRABORTI
Director ceased
SRABANI CHAKRABARTY
19 Nov 2012
Securities allotted
1000 Equity Shares Without Differential Rights - 10,000.00 raised
05 Sep 2012
Director ceased
LILLY BAKSHI
Director ceased
NARENDRA NATH CHOWDHURY
05 Jan 2011
Securities allotted
1000 Equity Shares Without Differential Rights - 10,000.00 raised
Securities allotted
6500 Equity Shares Without Differential Rights - 65,000.00 raised
27 Feb 2002
Director appointed
SHYAMA PAUL (Director)
Director appointed
SUPRIYA CHOWDHURY (Director)
Director appointed
PATIT PABAN CHOWDHURY (Director)
26 Feb 2002
Incorporated
Registered with Roc Kolkata I
10

Key Observations

Auto-generated from the data above
Revenue declined 2.1x over the last 4 financial year(s).
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a dominant controlling stake as per the FY 2019 annual return.
Capital has been raised through 3 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Final Medical Advise Private Limited U74140DL2014PTC269796 New Delhi, Delhi, India
Hibah Hospitality Private Limited U74110PN2004PTC019200 Lohagaon, Maharashtra, India
Lenon Healthcare Private Limited U93090DL2018PTC329238 New Delhi, Delhi, India
Universal Dr Life Family Clinic Private Limited U85100DL2019PTC351013 New Delhi, Delhi, India
Lotus Medical Devices India Private Limited U85110UP2003PTC027906 Yashoda Nagar, Uttar Pradesh, India
Mayarasa Foundation U85300DL2018NPL334686 New Delhi, Delhi, India
A2Z Home Patient Care Private Limited U85100HR2021PTC097290 Faridabad, Haryana, India
Novo Tissue Bank And Research Centre Private Limited U85300MH2020PTC350971 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Apex Medilink Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Apex Medilink Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 60/100, margin trends, ownership structure and peer set for Apex Medilink Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 90/100, distress signals and MSME payment-delay disclosures - know whether Apex Medilink Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Apex Medilink Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Apex Medilink Private Limited an active company?

Apex Medilink Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Apex Medilink Private Limited financially healthy?

Apex Medilink Private Limited has a Financial Health Score of 75/100 (Low Risk) based on its filed financial statements.

Should I do business with Apex Medilink Private Limited?

Its overall Trust Score is 90/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Apex Medilink Private Limited?

The ultimate holding entity is Vip Apex Medical Centre Private Limited. 3 active director(s) are on record.

Does Apex Medilink Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Apex Medilink Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Apex Medilink Private Limited?

Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.